Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INPPL1 | O15357 | 11/20 | 0.52 |
| ▸ | INPP5A | Q14642 | 6/20 | 0.52 |
| ▸ | INPP5B | P32019 | 2/20 | 0.52 |
| ▸ | AKT1 | P31749 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6057570 | 0.88 | ALDH1A1 (0.40) | ALDH1A1CYP3A4TSHRHSD17B10TDP1 | |
| SCHEMBL4372630 | 0.84 | INPPL1 (0.52) | INPPL1INPP5AINPP5BAKT1TSHR | |
| SCHEMBL5983682 | 0.83 | TP53 (0.42) | ALDH1A1CYP3A4TSHRHSD17B10TDP1 | |
| SCHEMBL2987764 | 0.82 | TP53 (0.41) | ALDH1A1CYP3A4TSHRHSD17B10TDP1 | |
| SCHEMBL27358799 | 0.81 | INPPL1 (0.48) | INPPL1INPP5AINPP5BAKT1ALDH1A1 | |
| SCHEMBL121443 | 0.80 | TTR (0.54) | INPPL1INPP5AINPP5BAKT1ALDH1A1 | |
| SCHEMBL8462654 | 0.78 | INPPL1 (0.45) | INPPL1INPP5AINPP5BAKT1ALDH1A1 | |
| SCHEMBL8460380 | 0.78 | INPPL1 (0.45) | INPPL1INPP5AINPP5BAKT1ALDH1A1 | |
| SCHEMBL4333883 | 0.78 | INPPL1 (0.45) | INPPL1INPP5AINPP5BAKT1ALDH1A1 | |
| SCHEMBL13342841 | 0.77 | TSHR (0.50) | INPPL1INPP5AINPP5BAKT1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6107039-A | MIXING SAMPLE OF NUCLEIC ACID SEQUENCE TO BE ANALYZED WITH OLIGONUCLEOTIDE PROBE CONTAINING AT LEAST ONE THIOL-PROTECTED PYRIMIDINE NUCLEOTIDE, EXPOSING TO ENDONUCLEASE, AND IDENTIFYING FRAGMENTS HAVING HYBRIDIZED PROBE | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA | 2000-08-22 | — | — | US | claimed |
| US-6008334-A | MODIFIED PYRIMIDINE NUCLEOSIDES/NUCLEOTIDES WITH PROTECTED THIOL GROUP ATTACHED AT 5 POSITION OF BASE THAT IS NOT INVOLVED IN WATSON-CRICK BASE PARING; FOR USE IN CHEMICAL AND ENZYMATIC SYNTHESIS OF NUCLEIC ACIDS | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 1999-12-28 | — | — | US | claimed |
| US-20230096149-A1 | Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides | APPLIED BIOSYSTEMS, LLC (US) | 2023-03-30 | — | — | US | disclosed |
| US-20220380845-A1 | Asymmetric Rhodamine Dye and Use Thereof in Biological Assays | Life Technologies Corporation | 2022-12-01 | — | — | US | disclosed |
| US-20220056041-A1 | Modified Rhodamine Dye and use Thereof in Biological Assays | Life Technologies Corporation | 2022-02-24 | — | — | US | disclosed |
| EP-3898842-A1 | MODIFIED RHODAMINE DYE AND USE THEREOF IN BIOLOGICAL ASSAYS | Life Technologies Corporation (US) | 2021-10-27 | — | — | EP | disclosed |
| EP-3898841-A1 | ASYMMETRIC RHODAMINE DYE AND USE THEREOF IN BIOLOGICAL ASSAYS | Life Technologies Corporation (US) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020132607-A9 | ASYMMETRIC RHODAMINE DYE AND USE THEREOF IN BIOLOGICAL ASSAYS | Life Technologies Corporation (US) | 2020-11-26 | — | — | WO | disclosed |
| US-20200270287-A1 | Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides | APPLIED BIOSYSTEMS, LLC (US) | 2020-08-27 | — | — | US | disclosed |
| WO-2020132487-A1 | MODIFIED RHODAMINE DYE AND USE THEREOF IN BIOLOGICAL ASSAYS | Life Technologies Corporation (US) | 2020-06-25 | — | — | WO | disclosed |
| WO-2020132607-A1 | ASYMMETRIC RHODAMINE DYE AND USE THEREOF IN BIOLOGICAL ASSAYS | Life Technologies Corporation (US) | 2020-06-25 | — | — | WO | disclosed |
| EP-2001871-A2 | REAGENTS USEFUL FOR SYNTHESIZING RHODAMINE-LABELED OLIGONUCLEOTIDES | APPLIED BIOSYSTEMS, INC. (US) | 2008-12-17 | — | — | EP | disclosed |
| US-20080071070-A1 | Coupling with phosphoramidite reagent; solid phase synthesis | APPLERA CORPORATION (US) | 2008-03-20 | — | — | US | disclosed |
| US-20070292733-A1 | Binder for Fuel Cell, Composition for Forming Electrode, Electrode, and Fuel Cell Using the Electrode | MITSUI CHEMICALS, INC. (JP) | 2007-12-20 | — | — | US | disclosed |
| WO-2007115265-A9 | REAGENTS USEFUL FOR SYNTHESIZING RHODAMINE-LABELED OLIGONUCLEOTIDES | APPLERA CORP (US) | 2007-11-29 | — | — | WO | disclosed |
| WO-2007115265-A2 | REAGENTS USEFUL FOR SYNTHESIZING RHODAMINE-LABELED OLIGONUCLEOTIDES | APPLIED BIOSYSTEMS INC. (US) | 2007-10-11 | — | — | WO | disclosed |
| EP-1788649-A1 | BINDER FOR FUEL CELL, COMPOSITION FOR ELECTRODE FORMATION, ELECTRODE, AND FUEL CELL USING THE ELECTRODE | Mitsui Chemicals, Inc. (JP) | 2007-05-23 | — | — | EP | disclosed |
| EP-1664341-A2 | SIZE-CONTROLLED MACROMOLECULE | Posco (KR) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005026191-A2 | SIZE-CONTROLLED MACROMOLECULE | POSCO (KR) | 2005-03-24 | — | — | WO | disclosed |
| US-20050037413-A1 | functionalized substrates bound to layers of dendrimers and to target-specific ligands, used in combinatorial chemistry, protein, nucleic acid or nucleic acid/peptide hybridization detection; medical diagnosis | POSCO (KR) | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220056041-A1 | Modified Rhodamine Dye and use Thereof in Biological Assays | QTRT1, MRPL21, RRP1B | INPPL1 2788/4885INPP5A 2414/4885INPP5B 3800/4885 |
| US-20080071070-A1 | Coupling with phosphoramidite reagent; solid phase synthesis | RTCB, RNGTT, PHAX | INPPL1 1401/4885INPP5A 2087/4885INPP5B 1125/4885 |
| US-20220380845-A1 | Asymmetric Rhodamine Dye and Use Thereof in Biological Assays | HNRNPR, RNASEH1, HNRNPH3 | INPPL1 2442/4885INPP5A 3784/4885INPP5B 4005/4885 |
| US-20200270287-A1 | Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides | RTCB, RRM2B, SNRPE | INPPL1 2270/4885INPP5A 3157/4885INPP5B 2433/4885 |
| US-20230096149-A1 | Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides | RTCB, RRM2B, SNRPE | INPPL1 2270/4885INPP5A 3157/4885INPP5B 2433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.